| Literature DB >> 26678390 |
Gregory N Ruegsegger1, Joseph M Company1, Ryan G Toedebusch1, Christian K Roberts2, Michael D Roberts1, Frank W Booth1,3,4,5.
Abstract
In maturing rats, the growth of abdominal fat is attenuated by voluntary wheel running. After the cessation of running by wheel locking, a rapid increase in adipose tissue growth to a size that is similar to rats that have never run (i.e. catch-up growth) has been previously reported by our lab. In contrast, diet-induced increases in adiposity have a slower onset with relatively delayed transcriptomic responses. The purpose of the present study was to identify molecular pathways associated with the rapid increase in adipose tissue after ending 6 wks of voluntary running at the time of puberty. Age-matched, male Wistar rats were given access to running wheels from 4 to 10 weeks of age. From the 10th to 11th week of age, one group of rats had continued wheel access, while the other group had one week of wheel locking. Perirenal adipose tissue was extracted, RNA sequencing was performed, and bioinformatics analyses were executed using Ingenuity Pathway Analysis (IPA). IPA was chosen to assist in the understanding of complex 'omics data by integrating data into networks and pathways. Wheel locked rats gained significantly more fat mass and significantly increased body fat percentage between weeks 10-11 despite having decreased food intake, as compared to rats with continued wheel access. IPA identified 646 known transcripts differentially expressed (p < 0.05) between continued wheel access and wheel locking. In wheel locked rats, IPA revealed enrichment of transcripts for the following functions: extracellular matrix, macrophage infiltration, immunity, and pro-inflammatory. These findings suggest that increases in visceral adipose tissue that accompanies the cessation of pubertal physical activity are associated with the alteration of multiple pathways, some of which may potentiate the development of pubertal obesity and obesity-associated systemic low-grade inflammation that occurs later in life.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26678390 PMCID: PMC4683046 DOI: 10.1371/journal.pone.0145229
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Transcript filtering after RNA-sequencing.
For each group, a transcript was omitted if it was not a known transcript or was not expressed in one experimental group. This filtering produced 16,918 and 17,128 known transcripts in the continued wheel access (RUN) and wheel locking (LOCK) groups, respectively. Between the RUN and LOCK groups, there were 16,610 commonly expressed genes that were compared and filtered for significance. A transcript was deemed significantly different between RUN and LOCK if: 1) false discover rate (FDR) < 0.1, 2) p<0.05, 3) fold change ≥ 1.5, and 4) average RPKM ≥ 1.5, 646 transcripts met these criteria. Of these 646 transcripts, 523 were up-regulated and 123 were down-regulated in LOCK, respectively. Abbreviations: Reads Per Kilobase Per Million Reads (RPKM); and Differentially Expressed Transcripts (DETs).
Primer sequences for gene expression analyzed by qRT-PCR.
| Gene | Forward (5’- 3’) | Reverse (5’- 3’) | Accession no. |
|---|---|---|---|
| 18S |
|
| NR_046237.1 |
| Col1a1 |
|
| NM_053304.1 |
| Col3a1 |
|
| NM_032085.1 |
| Tlr2 |
|
| NM_198769.2 |
| Cd36 |
|
| NM_031561.2 |
| Fabp3 |
|
| NM_024162.1 |
| Fabp4 |
|
| NM_053365.1 |
| Agpat9 |
|
| XM_008770019 |
| Cish |
|
| NM_031804.1 |
Animal characteristics.
| Measurements | RUN | LOCK |
|---|---|---|
| Body mass 10wk, g | 350.5 ± 13.7 | 346.5 ± 3.6 |
| Body mass 11wk, g | 364.8 ±13.9 | 370.3 ± 4.0 |
| Change in body mass (last 7 days), g | 14.3 ± 0.6 | 23.8 ± 2.0 |
| Lean mass 10wk, g | 324.0 ± 10.0 | 320.5 ±4.4 |
| Lean mass 11wk, g | 338.6 ± 10.7 | 335.1 ± 5.4 |
| Change in lean mass (last 7 days), g | 14.7 ± 1.9 | 14.6 ± 2.3 |
| Fat mass, 10wk, g | 26.6 ± 4.9 | 26.0 ± 2.7 |
| Fat mass, 11wk, g | 26.2 ± 5.0 | 35.1 ± 4.0 |
| Change in fat mass (last 7 days), g | -0.4 ± 1.9 | 9.1 ± 1.7 |
| Perirenal fat mass, g | 1.93 ± 0.26 | 3.43 ± 0.25 |
| Perirenal adipocyte diameter, μm | 62.2 ± 3.9 | 67.1 ± 1.4 |
| Perirenal depot cellularity (x 106) | 14.9 ± 1.1 | 24.2 ± 2.9 |
| Epididymal fat mass, g | 2.96 ± .017 | 4.04 ± 0.44 |
| Epididymal adipocyte diameter, μm | 64.8 ± 3.6 | 68.3 ± 2.3 |
| Epididymal depot cellularity (x 106) | 24.3 ± 3.4 | 26.3 ± 1.8 |
| Omental fat mass, g | 0.35 ± 0.02 | 0.47 ± 0.07 |
| Omental adipocyte diameter, μm | 51.7 ± 3.4 | 54.9 ± 2.4 |
| Omental depot cellularity (x 106) | 5.9 ± 1.0 | 5.8 ± 0.5 |
| Body fat % 10wk, g | 7.4 ± 1.1 | 7.5 ± 0.8 |
| Body fat % 11wk, g | 7.0 ± 1.1 | 9.5 ± 1.1 |
| Change in body fat % (last 7 days), g | -0.7 ± 0.4 | 2.0 ± 0.4 |
Student’s t-test was performed on each outcome measure for continued wheel access (RUN) and wheel locking (LOCK) groups. Values are means ± SE. n = 6 per group.
* denotes significant differences between groups at p<0.05.
Fig 2Daily food intake over the final 14 days.
The vertical dashed line represents the day of wheel locking (LOCK). Different letters denote significance among groups at p < 0.05, as determined by Student’s t-test.
Fig 3PRAT adipocyte size distribution.
Adipocyte diameters were classified in 10-μm categories [category #, adipocyte diameter range in μm (10: 0.0–9.0μm, 20: 10.0–19.9μm, 20: 20.0–29.9μm, etc.] on the x-axis; and the percentage of total adipocytes in a 10-μm category was plotted on y-axis. At least 300 adipocyte diameters were measured for each tissue sample. Different letters denote differences among groups at each 10-μm category, p<0.05, as determined by Student’s t-test.
Top 15 up and down regulated genes differentially expressed between continued wheel access (RUN) and wheel locking (LOCK), sorted by magnitude of fold change.
| Gene Transcript | Description | LOCK/RUN | RUN Average RPKM | LOCK Average RPKM |
|---|---|---|---|---|
|
| ||||
| RETNLG | Resistin-like gamma | 7.400 | 3.93 | 29.08 |
| CLEC11A | C-type lectin domain family 11, member A | 5.522 | 2.09 | 11.52 |
| LOX | Lysyl oxidase | 4.549 | 8.567 | 38.97 |
| SFRP1 | Secreted frizzled-related protein 1 | 4.281 | 4.221 | 18.08 |
| PTGIS | Protaglandin I2 synthase | 4.065 | 8.745 | 35.55 |
| FLRT2 | Fibronectin leucine rich transmembrane protein 2 | 3.987 | 2.778 | 11.08 |
| CCL13 | Chemokine (C-C motif) ligand 13 | 3.630 | 9.931 | 36.05 |
| MT2A | Metallothionein 2A | 3.488 | 3.772 | 13.16 |
| LUM | Lumican | 3.467 | 42.351 | 146.95 |
| C3 | Complement component 3 | 3.429 | 3.256 | 11.17 |
| FN1 | Fibronectin 1 | 3.396 | 59.75 | 202.91 |
| KIAA0101 | Kiaa0101 | 3.382 | 2.80 | 9.47 |
| SPON1 | Spondin 1 | 3.355 | 7.99 | 26.80 |
| ELN | Elastin | 3.296 | 35.10 | 115.71 |
| LYVE1 | Lymphatic vessel endothelial hyaluronan receptor 1 | 3.286 | 20.73 | 68.15 |
|
| ||||
| SYTL5 | Synaptotagmin-like 5 | -2.778 | 5.96 | 2.15 |
| FABP3 | Fatty acid binding protein 3 | -2.740 | 17.87 | 6.52 |
| CISH | Cytokine inducible SH2-containing protein | -2.470 | 30.12 | 12.19 |
| TMEFF1 | Transmembrane protein with EGF-like and two follistatin-like domains 1 | -2.456 | 15.11 | 6.15 |
| CALML3 | Calmodulin-like 3 | -2.377 | 17.35 | 7.30 |
| ADHFE1 | Alcohol dehydrogenase, iron containing, 1 | -2.359 | 8.97 | 3.80 |
| HOXA9 | Homeobox A9 | -2.288 | 49.27 | 21.54 |
| SIX1 | SIX homeobox 1 | -2.245 | 82.30 | 36.58 |
| UCP3 | Uncoupling protein 3 | -2.221 | 6.56 | 2.95 |
| KIFC2 | Kinesin family member 2 | -2.151 | 8.46 | 3.93 |
| CYP4F22 | Cytochrome P450, family 4, subfamily V, polypeptide 22 | -2.067 | 16.68 | 8.07 |
| TBATA | Thymus, brain and testes associated | -2.043 | 6.96 | 3.41 |
| NABP1 | Nucleic acid binding protein 1 | -1.980 | 106.20 | 53.64 |
| HOXC10 | Homeobox C10 | -1.973 | 5.86 | 2.97 |
| RESP18 | Regulated endocrine-specific protein 18 | -1.952 | 7.38 | 3.78 |
Top 10 genes expressed in RUN but not LOCK, sorted by average RPKM.
| Gene Transcript | Description | RUN RPKM |
|---|---|---|
| RFX4 | Regulatory factor X, 4 | 2.44 |
| HEY2 | Hairy/enhancer-of-split related with YRPW motif 2 | 2.53 |
| GIPR | Gastric inhibitory polypeptide receptor | 2.10 |
| TSHR | Thyroid stimulating hormone receptor | 2.01 |
| GRTP1 | Growth hormone regulated TBC protein 1 | 1.86 |
| NCKAP5 | NCK-associated protein 5 | 1.75 |
| ACE2 | Angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 | 1.67 |
| CLMP | CXADR-like membrane protein | 1.60 |
| PDE4C | Phosphodiesterase 4C, cAMP-specific | 1.52 |
| NEU2 | Sialidase 2 (cytosolic sialidase) | 1.48 |
Top 10 genes expressed in LOCK but not RUN, sorted by average RPKM.
| Gene Transcript | Description | LOCK RPKM |
|---|---|---|
| TOP2A | Topoisomerase (DNA) II alpha | 7.42 |
| CDKN3 | Cyclin-dependent kinase inhibitor 3 | 7.13 |
| MK167 | Antigen identified by monoclonal antibody Ki-67 | 5.87 |
| TPX2 | TPX2, microtubule-associated, homolog | 5.11 |
| NUSAP1 | Nucleolar and spindle associated protein 1 | 5.01 |
| CCNA2 | Cyclin A2 | 4.85 |
| RACGAP1 | Rac GTPase activating protein 1 | 4.58 |
| CKAP2 | Cytoskeleton associated protein 2 | 4.50 |
| AURKB | Aurora kinase B | 4.32 |
| KIF23 | Kinesin family member 23 | 4.16 |
List of transcripts from top scoring IPA networks inclusive of both up-regulated and down-regulated genes as influenced by wheel locking (LOCK) (score = 41 for both networks).
| Network: Cancer, organismal injury and abnormalities, and reproductive system disease (34 mRNAs) |
|
|
| Anxa2, Arhgap11a, Cd34, Cdca4, Celf2, Dnmt1, E2f1, Elf4, Fkpb10, H1fx, H2afx, Hmgb2, Mcm2, Mcm4, Mcm6, Nasp, Ndn, Orai2, Pcna, Pold3, Smoc2, Soga1, Spats2l, Wee1 |
|
|
| Cyc1, Hoxa9, Hspe1 |
|
|
| Cd3, Cdc2, Cyclin A, E2f, Histone h1, Histone h3, Histone h4 |
| Network: Lipid metabolism, small molecule biochemistry, cellular development (35 mRNAs) |
|
|
| Alcam, Aldh1a3, Alox5ap, B3gnt9, Card6, Coro1a, Dmbt1, Glrx, Lama2, Ltc4s, Minos1-nbl1/nbl1, Myo1e, Rab31, Rab3d, Rin3, Selplg, Soat1, Stk10, Tifa, Tpm3, Trafd1, Vnm1 |
|
|
| Cdkn2c, G0s2, Hmgcs1, Insig1, Phyh |
|
|
| Amylase, Bmp, Elastase, Ets, Fascin, Hmg CoA synthase, Igh (family), Nfkb (complex) |
Fig 4Top scoring network inclusive of up-regulated genes (score = 47) in LOCK vs RUN.
Nodes represent genes/molecules. Shading is proportional to fold change size (red: up-regulated). Direct and indirect relationships are denoted with solid and dashed lines, respectively. White nodes denote network members that were not altered in the network. Lines ending in an arrow or blunt end indicate known direction of molecular activation or inhibition, respectively. Different shapes of genes represent different gene functions.
Fig 5Second scoring network inclusive of up-regulated genes (score = 40) in LOCK vs RUN.
Nodes represent genes/molecules. Shading is proportional to fold change size (red: upregulated). Direct and indirect relationships are denoted with solid and dashed lines, respectively. White nodes denote network members that were not altered in the network. Lines ending in an arrow or blunt end indicate known direction of molecular activation or inhibition, respectively. Different shapes of genes represent different gene functions.
List of transcripts from top scoring IPA network inclusive of only down-regulated genes as influenced by wheel locking (LOCK) (score = 58).
| Network: Metabolic disease, lipid metabolism, molecular transport (35 mRNAs) |
|---|
|
|
| Acox1, Acsl1, Adipor2, Agpat9, Aig1, Alas1, Asns, Cd36, Ces1, Ces1d, Ces1e, Cntf, Dnajc15, Fabp4, Fdps, G0s2, Gpd1, Hmgcs1, Hspe1, Insig1, Kcnh2, Mvd, Oxct1, Pxmp2, Retsat, S100a1 |
|
|
| Fascin, Hla-dr, Ifn alpha receptor, Ifn alpha/beta, Ifn type 1, Ifnar, Igh (family), Mhc II, Nfkb (complex) |
Fig 6Top scoring network inclusive of genes expressed only in LOCK (score = 63).
Nodes represent genes/molecules. Shading is proportional to RPKM value. Direct and indirect relationships are denoted with solid and dashed lines, respectively. White nodes denote network members that were not altered in the network. Lines ending in an arrow or blunt end indicate known direction of molecular activation or inhibition, respectively. Different shapes of genes represent different gene functions.
Validation of select RNA-seq transcripts by qRT-PCR.
| RNA-seq | qRT-PCR | |||
|---|---|---|---|---|
| Transcript name | Fold change | P-value | Fold change | P-value |
| Col1a1 | 2.73 | 0.008 | 1.83 | < 0.001 |
| Col3a1 | 2.74 | 0.019 | 1.78 | < 0.001 |
| Tlr2 | 2.09 | 0.029 | 1.34 | 0.049 |
| Cd36 | -1.53 | < 0.001 | -1.49 | 0.003 |
| Fabp3 | -2.74 | 0.012 | -1.76 | 0.020 |
| Fabp4 | -1.73 | < 0.001 | -1.25 | 0.018 |
| Agpat9 | -1.68 | < 0.001 | -1.49 | 0.005 |
| Cish | -2.47 | 0.047 | -2.43 | 0.049 |
Fig 7Protein expression of A) Col1a1 and B) Cd36 in PRAT from continued wheel access (RUN) and wheel locking (LOCK) rats (n = 5 per group).
Protein expression was normalized for Ponceau S.